Mortality and clinical characteristics of multisystem inflammatory syndrome in children (MIS-C) associated with covid-19 in critically ill patients: an observational multicenter study (MISCO study)
Abstract Background The clinical presentation and severity of Multisystem Inflammatory Syndrome in Children associated with COVID-19 (MIS-C) is widespread and presents a very low mortality rate in high-income countries. This research describes the clinical characteristics of MIS-C in critically ill...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/864c1248aa4443e9bf330327a3fc0382 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:864c1248aa4443e9bf330327a3fc0382 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:864c1248aa4443e9bf330327a3fc03822021-11-21T12:33:28ZMortality and clinical characteristics of multisystem inflammatory syndrome in children (MIS-C) associated with covid-19 in critically ill patients: an observational multicenter study (MISCO study)10.1186/s12887-021-02974-91471-2431https://doaj.org/article/864c1248aa4443e9bf330327a3fc03822021-11-01T00:00:00Zhttps://doi.org/10.1186/s12887-021-02974-9https://doaj.org/toc/1471-2431Abstract Background The clinical presentation and severity of Multisystem Inflammatory Syndrome in Children associated with COVID-19 (MIS-C) is widespread and presents a very low mortality rate in high-income countries. This research describes the clinical characteristics of MIS-C in critically ill children in middle-income countries and the factors associated with the rate of mortality and patients with critical outcomes. Methods An observational cohort study was conducted in 14 pediatric intensive care units (PICUs) in Colombia between April 01, 2020, and January 31, 2021. Patient age ranged between one month and 18 years, and each patient met the requirements set forth by the World Health Organization (WHO) for MIS-C. Results There were seventy-eight children in this study. The median age was seven years (IQR 1-11), 18 % (14/78) were under one year old, and 56 % were male. 35 % of patients (29/78) were obese or overweight. The PICU stay per individual was six days (IQR 4-7), and 100 % had a fever upon arrival to the clinic lasting at least five days (IQR 3.7-6). 70 % (55/78) of patients had diarrhea, and 87 % (68/78) had shock or systolic myocardial dysfunction (78 %). Coronary aneurysms were found in 35 % (27/78) of cases, and pericardial effusion was found in 36 %. When compared to existing data in high-income countries, there was a higher mortality rate observed (9 % vs. 1.8 %; p=0.001). When assessing the group of patients that did not survive, a higher frequency of ferritin levels was found, above 500 ngr/mL (100 % vs. 45 %; p=0.012), as well as more cardiovascular complications (100 % vs. 54 %; p = 0.019) when compared to the group that survived. The main treatments received were immunoglobulin (91 %), vasoactive support (76 %), steroids (70.5 %) and antiplatelets (44 %). Conclusions Multisystem Inflammatory Syndrome in Children due to SARS-CoV-2 in critically ill children living in a middle-income country has some clinical, laboratory, and echocardiographic characteristics similar to those described in high-income countries. The observed inflammatory response and cardiovascular involvement were conditions that, added to the later presentation, may explain the higher mortality seen in these children.Lorena AcevedoByron Enrique Piñeres-OlaveLaura Fernanda Niño-SernaLiliana Mazzillo VegaIvan Jose Ardila GomezShayl ChacónJuan Camilo Jaramillo-BustamanteHernando Mulett-HoyosOtto González-PardoEliana ZemanateLedys IzquierdoJaime Piracoca MejìaJose Luis Junco GonzálezBeatriz Giraldo DuranCarolina Bonilla GonzalezHelen PreciadoRafael Orozco MarunMartha I Alvarez-OlmosCarolina Giraldo AlzateJorge RojasJuan Carlos Salazar-UribeJuan-Manuel AnayaJaime Fernández-SarmientoBMCarticleSepsisSARS-CoV2PIMS-TSinflammatorymortalityPediatricsRJ1-570ENBMC Pediatrics, Vol 21, Iss 1, Pp 1-12 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Sepsis SARS-CoV2 PIMS-TS inflammatory mortality Pediatrics RJ1-570 |
spellingShingle |
Sepsis SARS-CoV2 PIMS-TS inflammatory mortality Pediatrics RJ1-570 Lorena Acevedo Byron Enrique Piñeres-Olave Laura Fernanda Niño-Serna Liliana Mazzillo Vega Ivan Jose Ardila Gomez Shayl Chacón Juan Camilo Jaramillo-Bustamante Hernando Mulett-Hoyos Otto González-Pardo Eliana Zemanate Ledys Izquierdo Jaime Piracoca Mejìa Jose Luis Junco González Beatriz Giraldo Duran Carolina Bonilla Gonzalez Helen Preciado Rafael Orozco Marun Martha I Alvarez-Olmos Carolina Giraldo Alzate Jorge Rojas Juan Carlos Salazar-Uribe Juan-Manuel Anaya Jaime Fernández-Sarmiento Mortality and clinical characteristics of multisystem inflammatory syndrome in children (MIS-C) associated with covid-19 in critically ill patients: an observational multicenter study (MISCO study) |
description |
Abstract Background The clinical presentation and severity of Multisystem Inflammatory Syndrome in Children associated with COVID-19 (MIS-C) is widespread and presents a very low mortality rate in high-income countries. This research describes the clinical characteristics of MIS-C in critically ill children in middle-income countries and the factors associated with the rate of mortality and patients with critical outcomes. Methods An observational cohort study was conducted in 14 pediatric intensive care units (PICUs) in Colombia between April 01, 2020, and January 31, 2021. Patient age ranged between one month and 18 years, and each patient met the requirements set forth by the World Health Organization (WHO) for MIS-C. Results There were seventy-eight children in this study. The median age was seven years (IQR 1-11), 18 % (14/78) were under one year old, and 56 % were male. 35 % of patients (29/78) were obese or overweight. The PICU stay per individual was six days (IQR 4-7), and 100 % had a fever upon arrival to the clinic lasting at least five days (IQR 3.7-6). 70 % (55/78) of patients had diarrhea, and 87 % (68/78) had shock or systolic myocardial dysfunction (78 %). Coronary aneurysms were found in 35 % (27/78) of cases, and pericardial effusion was found in 36 %. When compared to existing data in high-income countries, there was a higher mortality rate observed (9 % vs. 1.8 %; p=0.001). When assessing the group of patients that did not survive, a higher frequency of ferritin levels was found, above 500 ngr/mL (100 % vs. 45 %; p=0.012), as well as more cardiovascular complications (100 % vs. 54 %; p = 0.019) when compared to the group that survived. The main treatments received were immunoglobulin (91 %), vasoactive support (76 %), steroids (70.5 %) and antiplatelets (44 %). Conclusions Multisystem Inflammatory Syndrome in Children due to SARS-CoV-2 in critically ill children living in a middle-income country has some clinical, laboratory, and echocardiographic characteristics similar to those described in high-income countries. The observed inflammatory response and cardiovascular involvement were conditions that, added to the later presentation, may explain the higher mortality seen in these children. |
format |
article |
author |
Lorena Acevedo Byron Enrique Piñeres-Olave Laura Fernanda Niño-Serna Liliana Mazzillo Vega Ivan Jose Ardila Gomez Shayl Chacón Juan Camilo Jaramillo-Bustamante Hernando Mulett-Hoyos Otto González-Pardo Eliana Zemanate Ledys Izquierdo Jaime Piracoca Mejìa Jose Luis Junco González Beatriz Giraldo Duran Carolina Bonilla Gonzalez Helen Preciado Rafael Orozco Marun Martha I Alvarez-Olmos Carolina Giraldo Alzate Jorge Rojas Juan Carlos Salazar-Uribe Juan-Manuel Anaya Jaime Fernández-Sarmiento |
author_facet |
Lorena Acevedo Byron Enrique Piñeres-Olave Laura Fernanda Niño-Serna Liliana Mazzillo Vega Ivan Jose Ardila Gomez Shayl Chacón Juan Camilo Jaramillo-Bustamante Hernando Mulett-Hoyos Otto González-Pardo Eliana Zemanate Ledys Izquierdo Jaime Piracoca Mejìa Jose Luis Junco González Beatriz Giraldo Duran Carolina Bonilla Gonzalez Helen Preciado Rafael Orozco Marun Martha I Alvarez-Olmos Carolina Giraldo Alzate Jorge Rojas Juan Carlos Salazar-Uribe Juan-Manuel Anaya Jaime Fernández-Sarmiento |
author_sort |
Lorena Acevedo |
title |
Mortality and clinical characteristics of multisystem inflammatory syndrome in children (MIS-C) associated with covid-19 in critically ill patients: an observational multicenter study (MISCO study) |
title_short |
Mortality and clinical characteristics of multisystem inflammatory syndrome in children (MIS-C) associated with covid-19 in critically ill patients: an observational multicenter study (MISCO study) |
title_full |
Mortality and clinical characteristics of multisystem inflammatory syndrome in children (MIS-C) associated with covid-19 in critically ill patients: an observational multicenter study (MISCO study) |
title_fullStr |
Mortality and clinical characteristics of multisystem inflammatory syndrome in children (MIS-C) associated with covid-19 in critically ill patients: an observational multicenter study (MISCO study) |
title_full_unstemmed |
Mortality and clinical characteristics of multisystem inflammatory syndrome in children (MIS-C) associated with covid-19 in critically ill patients: an observational multicenter study (MISCO study) |
title_sort |
mortality and clinical characteristics of multisystem inflammatory syndrome in children (mis-c) associated with covid-19 in critically ill patients: an observational multicenter study (misco study) |
publisher |
BMC |
publishDate |
2021 |
url |
https://doaj.org/article/864c1248aa4443e9bf330327a3fc0382 |
work_keys_str_mv |
AT lorenaacevedo mortalityandclinicalcharacteristicsofmultisysteminflammatorysyndromeinchildrenmiscassociatedwithcovid19incriticallyillpatientsanobservationalmulticenterstudymiscostudy AT byronenriquepineresolave mortalityandclinicalcharacteristicsofmultisysteminflammatorysyndromeinchildrenmiscassociatedwithcovid19incriticallyillpatientsanobservationalmulticenterstudymiscostudy AT laurafernandaninoserna mortalityandclinicalcharacteristicsofmultisysteminflammatorysyndromeinchildrenmiscassociatedwithcovid19incriticallyillpatientsanobservationalmulticenterstudymiscostudy AT lilianamazzillovega mortalityandclinicalcharacteristicsofmultisysteminflammatorysyndromeinchildrenmiscassociatedwithcovid19incriticallyillpatientsanobservationalmulticenterstudymiscostudy AT ivanjoseardilagomez mortalityandclinicalcharacteristicsofmultisysteminflammatorysyndromeinchildrenmiscassociatedwithcovid19incriticallyillpatientsanobservationalmulticenterstudymiscostudy AT shaylchacon mortalityandclinicalcharacteristicsofmultisysteminflammatorysyndromeinchildrenmiscassociatedwithcovid19incriticallyillpatientsanobservationalmulticenterstudymiscostudy AT juancamilojaramillobustamante mortalityandclinicalcharacteristicsofmultisysteminflammatorysyndromeinchildrenmiscassociatedwithcovid19incriticallyillpatientsanobservationalmulticenterstudymiscostudy AT hernandomuletthoyos mortalityandclinicalcharacteristicsofmultisysteminflammatorysyndromeinchildrenmiscassociatedwithcovid19incriticallyillpatientsanobservationalmulticenterstudymiscostudy AT ottogonzalezpardo mortalityandclinicalcharacteristicsofmultisysteminflammatorysyndromeinchildrenmiscassociatedwithcovid19incriticallyillpatientsanobservationalmulticenterstudymiscostudy AT elianazemanate mortalityandclinicalcharacteristicsofmultisysteminflammatorysyndromeinchildrenmiscassociatedwithcovid19incriticallyillpatientsanobservationalmulticenterstudymiscostudy AT ledysizquierdo mortalityandclinicalcharacteristicsofmultisysteminflammatorysyndromeinchildrenmiscassociatedwithcovid19incriticallyillpatientsanobservationalmulticenterstudymiscostudy AT jaimepiracocamejia mortalityandclinicalcharacteristicsofmultisysteminflammatorysyndromeinchildrenmiscassociatedwithcovid19incriticallyillpatientsanobservationalmulticenterstudymiscostudy AT joseluisjuncogonzalez mortalityandclinicalcharacteristicsofmultisysteminflammatorysyndromeinchildrenmiscassociatedwithcovid19incriticallyillpatientsanobservationalmulticenterstudymiscostudy AT beatrizgiraldoduran mortalityandclinicalcharacteristicsofmultisysteminflammatorysyndromeinchildrenmiscassociatedwithcovid19incriticallyillpatientsanobservationalmulticenterstudymiscostudy AT carolinabonillagonzalez mortalityandclinicalcharacteristicsofmultisysteminflammatorysyndromeinchildrenmiscassociatedwithcovid19incriticallyillpatientsanobservationalmulticenterstudymiscostudy AT helenpreciado mortalityandclinicalcharacteristicsofmultisysteminflammatorysyndromeinchildrenmiscassociatedwithcovid19incriticallyillpatientsanobservationalmulticenterstudymiscostudy AT rafaelorozcomarun mortalityandclinicalcharacteristicsofmultisysteminflammatorysyndromeinchildrenmiscassociatedwithcovid19incriticallyillpatientsanobservationalmulticenterstudymiscostudy AT marthaialvarezolmos mortalityandclinicalcharacteristicsofmultisysteminflammatorysyndromeinchildrenmiscassociatedwithcovid19incriticallyillpatientsanobservationalmulticenterstudymiscostudy AT carolinagiraldoalzate mortalityandclinicalcharacteristicsofmultisysteminflammatorysyndromeinchildrenmiscassociatedwithcovid19incriticallyillpatientsanobservationalmulticenterstudymiscostudy AT jorgerojas mortalityandclinicalcharacteristicsofmultisysteminflammatorysyndromeinchildrenmiscassociatedwithcovid19incriticallyillpatientsanobservationalmulticenterstudymiscostudy AT juancarlossalazaruribe mortalityandclinicalcharacteristicsofmultisysteminflammatorysyndromeinchildrenmiscassociatedwithcovid19incriticallyillpatientsanobservationalmulticenterstudymiscostudy AT juanmanuelanaya mortalityandclinicalcharacteristicsofmultisysteminflammatorysyndromeinchildrenmiscassociatedwithcovid19incriticallyillpatientsanobservationalmulticenterstudymiscostudy AT jaimefernandezsarmiento mortalityandclinicalcharacteristicsofmultisysteminflammatorysyndromeinchildrenmiscassociatedwithcovid19incriticallyillpatientsanobservationalmulticenterstudymiscostudy |
_version_ |
1718418956133335040 |